The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $616,598 in first-year total cost, median $616,598.
Most frequent study sections
- Neurological Sciences and Disorders A Study Section[NSD-A]1
Most frequent institutions
- NERVIVE, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Early Feasibility Clinical Study of the VitalFlow Stimulator, an Emergency Treatment for Ischemic Stroke1U44NS094307-01A1 | HARRINGTON, STEPHANIE ADISACRISTAN, EMILIO | NERVIVE, INC., OH | $616,598 | NSD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.